Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-14-Speech-4-330-875"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-06-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20120614.22.4-330-875"2
lpv:hasSubsequent	lp_eu:2012-06-14-Speech-4-331-0002
lpv:speaker	lp:Françoise Castex2
lpv:spokenAs	member; CRIM (2012-03-28--2013-10-23)3 vice-chair; JURI (2012-03-01--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; EMPL (2012-01-19--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 unknown; Parti socialiste (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN) (2009-09-16--2014-06-30)3
lpv:translated text	"The PIP breast implants scandal – which broke in March 2010 – has brought to light the serious malfunctions in European health safety. These tragedies are forcing us to carry out an in-depth review of the functioning of the European and national bodies responsible for health matters. Parliament’s reaction is in line with the gravity of the scandal: the resolution, which I voted for, calls for greater cooperation between Member States and greater control measures for medical devices placed on the market. This is an ambitious resolution in my view, as it also calls on the Commission to consider a system of pre-market authorisation for certain categories of medical devices."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph